The effect of advertising in clinical software on general practitioners’ prescribing behaviour

James F Reeve, Judith M Mackson, Michelle Sweidan and Margaret Williamson
Med J Aust 2008; 189 (2): . || doi: 10.5694/j.1326-5377.2008.tb01923.x
Published online: 21 July 2008

To the Editor: The observational study by Henderson and colleagues1 is important, as it is the first to look at the effect of advertising in clinical software on prescribing behaviour in Australia. However, the stated conclusion — that “exposure to advertisements in clinical software has little influence on the prescribing behaviour of [general practitioners]” — requires qualification, as there were potentially important confounders including the effects of other forms of pharmaceutical promotion that were not evaluated.

  • James F Reeve
  • Judith M Mackson
  • Michelle Sweidan
  • Margaret Williamson

  • Pharmaceutical Decision Support Program, National Prescribing Service Limited, Sydney, NSW.


Competing interests:

The National Prescribing Service develops and maintains decision support prompts in several GP clinical software packages to alert GPs to independent, evidence-based drug information for new drugs (NPS RADAR).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.